[Prophylaxis and therapy of post-traumatic stress disorder with propranolol: evidence and ethical analysis]

Nervenarzt. 2013 Oct;84(10):1183-9. doi: 10.1007/s00115-013-3735-6.
[Article in German]

Abstract

The beta-antagonistic agent propranolol is increasingly being used in clinical trials for the prophylaxis and treatment of post-traumatic stress disorder (PTSD). This article discusses the evidence for the effectiveness of propranolol in the prophylaxis and treatment of PTSD and the ethical implications of research on these treatment approaches. The efficacy of a prophylactic or therapeutic use could not be shown during the last decade. Both treatment approaches raise ethical questions that should already be addressed during the clinical trials.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use*
  • Animals
  • Arousal / drug effects
  • Combined Modality Therapy
  • Disease Models, Animal
  • Ethics, Medical*
  • Evidence-Based Medicine / ethics*
  • Humans
  • Informed Consent
  • Memory, Episodic
  • Propranolol / adverse effects
  • Propranolol / therapeutic use*
  • Psychotherapy
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Stress Disorders, Post-Traumatic / drug therapy*
  • Stress Disorders, Post-Traumatic / prevention & control*
  • Stress Disorders, Post-Traumatic / psychology

Substances

  • Adrenergic beta-Antagonists
  • Propranolol